Published in Clinicoecon Outcomes Res on April 10, 2017
Adherence to medication. N Engl J Med (2005) 39.77
Effects of a fixed-dose combination strategy on adherence and risk factors in patients with or at high risk of CVD: the UMPIRE randomized clinical trial. JAMA (2013) 4.82
Full coverage for preventive medications after myocardial infarction. N Engl J Med (2011) 4.51
Primary medication non-adherence: analysis of 195,930 electronic prescriptions. J Gen Intern Med (2010) 3.57
Unaffordable drug prices: the major cause of non-compliance with hypertension medication in Ghana. J Pharm Pharm Sci (2004) 1.93
Worldwide epidemic of hypertension. Can J Cardiol (2006) 1.55
The economic impact of hypertension. J Clin Hypertens (Greenwich) (2003) 1.16
Prevalence of hypertension and its complications among medical admissions at the University of Nigeria Teaching Hospital, Enugu (Study 2). Niger J Med (2009) 1.08
The managed hypertensive: the costs of blood pressure control in a Nigerian town. Pan Afr Med J (2012) 0.98
Pharmacoeconomic challenges in disease management of hypertension. J Hypertens Suppl (2001) 0.95
Telemonitoring and Protocolized Case Management for Hypertensive Community-Dwelling Seniors With Diabetes: Protocol of the TECHNOMED Randomized Controlled Trial. JMIR Res Protoc (2016) 0.82
Healthcare Costs Attributable to Hypertension: Canadian Population-Based Cohort Study. Hypertension (2015) 0.81
Antihypertensive treatment - navigating between cost, compliance and complications. Swiss Med Wkly (2013) 0.79
The Hospitalization Costs of Diabetes and Hypertension Complications in Zimbabwe: Estimations and Correlations. J Diabetes Res (2016) 0.79